Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
24.82
+0.82 (3.42%)
At close: Mar 9, 2026, 4:00 PM EDT
24.70
-0.12 (-0.48%)
After-hours: Mar 9, 2026, 6:20 PM EDT

Arcutis Biotherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2017
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2017
Market Capitalization
3,0793,5571,6303059011,043
Upgrade
Market Cap Growth
95.99%118.17%434.82%-66.18%-13.58%-14.88%
Upgrade
Enterprise Value
2,8993,4801,508283626681
Upgrade
Last Close Price
24.0029.0413.933.2314.8020.74
Upgrade
Forward PE
67.6076.62----
Upgrade
PS Ratio
7.999.468.305.11244.56-
Upgrade
PB Ratio
15.6218.7710.353.444.303.50
Upgrade
P/TBV Ratio
17.2120.3611.013.714.453.50
Upgrade
EV/Sales Ratio
7.719.257.674.75169.88-
Upgrade
Debt / Equity Ratio
0.600.600.702.320.970.26
Upgrade
Net Debt / Equity Ratio
-0.56-0.56-0.75-0.74-0.99-1.04
Upgrade
Net Debt / EBITDA Ratio
14.1214.120.940.270.691.50
Upgrade
Net Debt / FCF Ratio
16.9216.921.050.270.801.76
Upgrade
Asset Turnover
0.960.960.570.150.01-
Upgrade
Inventory Turnover
1.981.981.380.48--
Upgrade
Quick Ratio
2.832.833.726.3811.0611.61
Upgrade
Current Ratio
3.173.174.147.0811.5712.09
Upgrade
Return on Equity (ROE)
-9.30%-9.30%-113.76%-175.79%-122.80%-72.62%
Upgrade
Return on Assets (ROA)
-1.96%-1.96%-23.25%-38.12%-43.97%-36.55%
Upgrade
Return on Capital Employed (ROCE)
-4.00%-4.00%-47.90%-81.80%-73.30%-55.10%
Upgrade
Earnings Yield
-0.54%-0.45%-8.59%-85.99%-34.55%-19.78%
Upgrade
FCF Yield
-0.21%-0.18%-6.89%-81.18%-28.63%-16.84%
Upgrade
Buyback Yield / Dilution
-5.19%-5.19%-74.53%-25.94%-11.39%-38.52%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.